Industry News
Method Developed To Determine Order Of Mutations That Lead To Cancer
Jul 01, 2011
Discovery underscores how understanding the abnormalities that develop in the beginning stages of cancer can identify the root causes of the disease. Zeroing in on the early cell mutations that enable a cancer to grow is one of the best ways to find a personalized therapy to stop it... Read More
Breakthrough Gene "Road Map" Guides Future Ovarian Cancer Research
Jun 30, 2011
Scientists have announced this week that they've uncovered a genetic map that will help determine the future of ovarian cancer research for years to come. The largest undertaking of its kind to date has led to a better understanding of this "silent killer" and ways to treat it... Read More
Detailed Ovarian Cancer Analysis Completed By The Cancer Genome Atlas
Jun 30, 2011
An analysis of genomic changes in ovarian cancer has provided the most comprehensive and integrated view of cancer genes for any cancer type to date. Ovarian serous adenocarcinoma tumors from 500 patients were examined by The Cancer Genome Atlas (TCGA) Research Network and analyses are reported in the June 30, 2011, issue of Nature... Read More
Evolution Of Skin And Ovarian Cancer Cells Decoded
Jun 30, 2011
A team of researchers led by scientists at the University of California, San Francisco has developed a way to uncover the evolution of human cancer cells, determining the order in which mutations emerge in them as they wend their way from a normal, healthy state into invasive, malignant masses... Read More
Ovarian Cancer Breakthrough Found In Cellular Enzyme That Switches On Resistance To Chemo Drugs
Jun 29, 2011
The discovery that a cellular enzyme switches on a gene that makes ovarian cancer cells resist the most commonly used chemotherapy drugs, is being heralded as a significant breakthrough, with the hope it will lead to new treatments that prolong survival for women in the advanced stages of a disease that currently has a very poor outlook... Read More
Photocure Initiates Enrolment Into Phase II Trial Of Cevira(R) For Cervical HPV Infection
Jun 20, 2011
Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology, has initiated patient enrolment in the first trial to evaluate the optimal dose and safety of Cevira, a novel integrated intravaginal drug-delivery device... Read More
Down Under Research Links HPV Vaccine With Cervical Cancer Prevention
Jun 17, 2011
Researchers from Australia have found that when administering human papillomavirus (HPV) vaccinations to women, there is also a reduction of high-grade cervical abnormalities (HGAs), which are the first warning signs of a developing cervical cancer... Read More
Study Is First To Show Reduction In High-Grade Cervical Abnormalities Following Implementation Of Human Papillomavirus (HPV) Vaccination Programmes
Jun 16, 2011
A study from Australia is the first to show reduction of high-grade cervical abnormalities (HGAs-the precursors to cervical cancer) in a population of women following introduction of human papillomavirus (HPV) vaccination programmes. However, the authors add that more work is needed to link this lower incidence definitively to vaccination status... Read More
Ovarian Cancer Cells Force Their Way Through Tissue
Jun 15, 2011
A team led by Joan Brugge, the Louise Foote Pfeiffer Professor of Cell Biology at Harvard Medical School, recently shed light on how ovarian cancer spreads... Read More
Scientists Image Beginning Stages Of Ovarian Cancer Growth With Time Lapse Technique
Jun 14, 2011
Scientists at Harvard University have created a laboratory model using time-lapse video microscopic technology that allows observation of early stages of ovarian cancer metastasis. "We were able to observe key molecular mechanisms that are necessary for the force-dependent processes associated with metastasis," said Joan Brugge, Ph.D., professor and chair of cell biology at Harvard University... Read More
Previous Page Next Page